Prosecution Insights
Last updated: October 27, 2026

Pancham Bakshi, USPTO Patent Examiner

Listed by the USPTO as BAKSHI, PANCHAM

Tech Center 1700 • Art Units: 1621 1623 1652 1671 1673 1712 1718

This examiner grants 77% of resolved cases

Analysis

BAKSHI, PANCHAM works in Tech Center 1700 and Art Unit 1621, with 1174 resolved cases. The allowance rate is 76.7%, while the median time to allowance is 839 days. This combination indicates a large examination record and a high rate of cases reaching allowance, with the median resolution period remaining substantial.

The interview lift is 30.2%, supporting interviews as one potentially useful part of prosecution planning. The listed companies are Dow Global Technologies LLC, The Regents of the University of California, and Entegris Inc. The leading firms are STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C., COOLEY LLP, and FOLEY & LARDNER LLP. Counsel handling matters in this unit can use the profile to calibrate amendment timing and interview preparation.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

76.7%
Allow Rate
+11.7% vs TC avg
1,248
Total Applications
+30.2%
Interview Lift
839
Avg Prosecution Days
Based on 1174 resolved cases, 2023–2026

Rejection Statute Breakdown

1.6%
§101 Eligibility
20.1%
§102 Novelty
30.5%
§103 Obviousness
30.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18927285 SILICON PRECURSOR COMPOUND AND PREPARATION METHOD THEREFOR, AND SILICON-CONTAINING THIN FILM PREPARATION METHOD USING SILICON PRECURSOR Non-Final OA MERCK PATENT GmbH
16825269 BORONIC ESTER PRODRUGS AND USES THEREOF Non-Final OA Dana-Farber Cancer Institute, Inc.
18626102 AUTOXIDATION CATALYSIS FOR CARBON CARBON BOND CLEAVAGE IN LIGNIN Non-Final OA Wisconsin Alumni Research Foundation
18441651 MONOMER COMPOUNDS FOR 3D PRINTING RESINS Non-Final OA Align Technology, Inc.
18100204 IMMUNOMODULATORY OLIGOSACCHARIDES Non-Final OA The Regents of the University of California
17925266 USE OF ALKANOLAMINES FOR LIGNIN EXTRACTION IN THE PRETREATMENT OF BIOMASS Final Rejection The Regents of the University of California
18255751 COMPOSITION FOR PRETERM INFANTS TO REDUCE TIME TO FULL ENTERAL FEEDING Final Rejection SOCIETE DES PRODUITS NESTLE S.A.
18108327 MOLYBDENUM(0) PRECURSORS FOR DEPOSITION OF MOLYBDENUM FILMS Non-Final OA Applied Materials, Inc.
18291294 STEREOSELECTIVE PREPARATION OF TRANS HALO CYCLOBUTANE Final Rejection AMGEN INC.
18697946 METHOD FOR PRODUCING HEXAFLUORO-1,3-BUTADIENE Non-Final OA RESONAC CORPORATION
17436023 COMPOSITIONS OF MATTER WITH ACTIVITY TO REMOVE LIPOFUSCIN FROM RETINAL CELLS Non-Final OA Cornell University
18240151 BIS (ARENE) METAL COMPLEXES AND RELATED METHODS Non-Final OA ENTEGRIS, INC.
18239661 INDENYL PRECURSORS Non-Final OA ENTEGRIS, INC.
17837904 SEMI-SOLID STATE NUCLEIC ACID MANIPULATION Non-Final OA Keygene N.V.
18254453 METHOD FOR ISOLATING CARBOXYLIC ACID FROM AN AQUEOUS SIDE STREAM WITH CO-PRODUCTION OF ALKALI METAL SALT Final Rejection NOURYON CHEMICALS INTERNATIONAL B.V.
18245905 PROCESSES OF PREPARING FERROCENE LIGAND MIXTURES SUITABLE FOR PROPYLENE HYDROFORMYLATION Non-Final OA Eastman Chemical Company
18681929 HETEROGENEOUS CATALYST COMPRISING A TRANSITION METAL ON A ZEOLITE CARRIER AND THE USE OF SUCH CATALYST IN A PROCESS FOR PRODUCING AN ETHER Non-Final OA The Board of Trustees of the University of Illinois
18239460 COMPOSITIONS COMPRISING DECITABINE AND TETRAHYDROURIDINE AND USES THEREOF Non-Final OA The Board of Trustees of the University of Illinois
18695916 POLYETHER POLYMERIZATION PROCESS Non-Final OA Dow Global Technologies LLC
18686783 ISOLATION OF DIALKYLENE PHENOLIC GLYCOL ETHER Non-Final OA Dow Global Technologies LLC
17925107 METHOD FOR THE HYDROSILYLATION OF AN OLEFINIC NITRILE AND A HYDRIDOSILANE Non-Final OA Dow Global Technologies LLC
18708329 METHOD FOR PREPARATION OF HIGH PURITY (METH)ACRYLIC ACID Non-Final OA LG CHEM, LTD.
19109585 SHIELDING COMPOUND, METHOD OF FORMING THIN FILM USING SHIELDING COMPOUND, AND SEMICONDUCTOR SUBSTRATE AND SEMICONDUCTOR DEVICE FABRICATED USING METHOD Final Rejection SOULBRAIN CO., LTD.
18269320 METHOD OF PRODUCING OXIDIZED CELLULOSE AND NANOCELLULOSE Final Rejection TOAGOSEI CO., LTD.
18041582 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND Final Rejection KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
18579439 METAL-ORGANIC FRAMEWORK Non-Final OA THE UNIVERSITY OF LIVERPOOL

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Pancham Bakshi's allowance rate?

76.7% of resolved applications examined by Pancham Bakshi were allowed (1,174 resolved cases), compared with 46.0% across Art Unit 1621 over the last five years.

Does an interview help with examiner Pancham Bakshi?

This examiner's interview lift is +30.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Pancham Bakshi take to allow a patent?

Applications allowed by Pancham Bakshi took 839 days on average from filing to allowance.

Which art unit does examiner Pancham Bakshi work in?

Pancham Bakshi examines applications in Art Unit 1621 in Tech Center 1700 (Chemistry & Materials).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month